Commerce RI approves incentives for new Amgen biomanufacturing facility

Chris Bergenheim

04/10/2018

PREPARING FOR SUCCESS: Amgen Rhode Island senior associates Devon Zayas, left, and Scott Lyons conduct a safety check prior to using a bioreactor at the company’s West Greenwich facility. / PBN PHOTO/ RUPERT WHITELEY — PREPARING FOR SUCCESS: Amgen Rhode Island senior associates Devon Zayas, left, and Scott Lyons conduct a safety check prior to using a bioreactor at the company’s West Greenwich facility. / PBN FILE PHOTO/RUPERT WHITELEY

PROVIDENCE – The R.I. Commerce Corp on Tuesday approved approximately $8.2 million in incentives with the possibility for up to $9.4 million in incentives for Immunex Rhode Island Corp., a subsidiary of Amgen Inc., for the construction of an approximately $165 million “next-generation” biomanufacturing facility in West Greenwich. The plant will be built on the current…

Register to keep reading or subscribe today and receive unlimited access.
Already a Subscriber?

If you have already logged in and are still seeing this message, please refresh the page as your browser is caching the old content.

Want to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.